Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of investors who purchased common stock of Inspire Medical Systems, Inc. during the specified Class Period, highlighting potential misrepresentation regarding the market demand for its sleep apnea device, Inspire V [2][6]. Group 1: Class Action Details - The class action lawsuit pertains to purchases made between August 6, 2024, and August 4, 2025, and aims to address alleged misrepresentations by the company regarding the demand and launch of the Inspire V device [2][6]. - Investors who purchased Inspire Medical common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Legal Process and Participation - Interested investors can join the class action by submitting a form or contacting the law firm directly, with a deadline to serve as lead plaintiff set for January 5, 2026 [4][7]. - It is noted that no class has been certified yet, meaning investors are not represented by counsel unless they retain one [8]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5]. - The firm has consistently ranked highly in terms of securities class action settlements and has recovered hundreds of millions of dollars for investors over the years [5].
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP